Recent changes
Jump to navigation
Jump to search
Track the most recent changes to the wiki on this page.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
10 May 2024
|
|
18:12 | Sotagliflozin 4 changes history +2,794 [Alen Antony (4×)] | |||
|
|
18:12 (cur | prev) +833 Alen Antony talk contribs | ||||
|
|
17:54 (cur | prev) +545 Alen Antony talk contribs | ||||
|
|
17:46 (cur | prev) +744 Alen Antony talk contribs | ||||
|
|
17:12 (cur | prev) +672 Alen Antony talk contribs | ||||
|
|
m 17:02 | Non-degenerate nucleotides per response element 4 changes history +94 [Marshallsumter (4×)] | |||
| m |
|
17:02 (cur | prev) +53 Marshallsumter talk contribs (→Tabulation of counts) | |||
| m |
|
06:35 (cur | prev) −8 Marshallsumter talk contribs (→Tabulation of counts) | |||
| m |
|
06:32 (cur | prev) 0 Marshallsumter talk contribs (→Tabulation of counts) | |||
| m |
|
06:16 (cur | prev) +49 Marshallsumter talk contribs (→Tabulation of counts) | |||
| 04:13 | Electronic medical record diffhist +119 Badgettrg talk contribs (→Problem lists) | ||||
| 01:58 | User:Archana.vajjala diffhist +2 Archana.vajjala talk contribs | ||||
9 May 2024
|
|
N 23:59 | Sotagliflozin 3 changes history +1,667 [Alen Antony (3×)] | |||
|
|
23:59 (cur | prev) +19 Alen Antony talk contribs | ||||
|
|
15:17 (cur | prev) +1,230 Alen Antony talk contribs | ||||
| N |
|
04:57 (cur | prev) +418 Alen Antony talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag={{AAP}} |genericName=sotagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=prophylaxis |indication=heart failure in patients with risk of heart failure, type 2 diabetes mellitus, chronic kidney disease, and other cardiovascular risk factors. |adverseReactions=urinary tract infection, volume depletion, diarrhea, and hypoglycemia. }}") | |||
| 14:35 | User:Rithish Nimmagadda diffhist +123 Rithish Nimmagadda talk contribs (→Education) | ||||
|
|
N 14:32 | Epcoritamab-bysp 3 changes history +11,459 [Rithish Nimmagadda (3×)] | |||
|
|
14:32 (cur | prev) +11,409 Rithish Nimmagadda talk contribs | ||||
|
|
13:14 (cur | prev) +4 Rithish Nimmagadda talk contribs | ||||
| N |
|
13:10 (cur | prev) +46 Rithish Nimmagadda talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=VSRN }}") | |||
|
|
N 10:45 | FUTIBATINIB 2 changes history +1,225 [Hafiza Amna Qadeer (2×)] | |||
|
|
10:45 (cur | prev) −12 Hafiza Amna Qadeer talk contribs | ||||
| N |
|
10:37 (cur | prev) +1,237 Hafiza Amna Qadeer talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=HAFIZA AMNA QADEER, MD |OTC=Yes |genericName=FUTIBATINIB |aOrAn=a |drugClass=Kinase Inhibitor |indicationType=treatment |indication=* of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. |adverseReactions=1* Nail Toxicity, stomatitis, dry skin, dry eye, alopecia 2* Musculos...") | |||
8 May 2024
| 21:38 | Template:KDRG diffhist +174 Kosar Doraghi talk contribs | ||||
|
|
N 21:38 | EXXUA 2 changes history +11,572 [Kosar Doraghi (2×)] | |||
|
|
21:38 (cur | prev) +11 Kosar Doraghi talk contribs | ||||
| N |
|
21:32 (cur | prev) +11,561 Kosar Doraghi talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=Gepirone |aOrAn=a |drugClass=extended-release tablets |indicationType=treatment |indication=major depressive disorder (MDD) in adults |hasBlackBoxWarning=Yes |adverseReactions=dizziness, nausea, insomnia, abdominal pain, and dyspepsia |blackBoxWarningTitle=WARNING: SUICIDAL THOUGHTS AND BEHAVIORS |blackBoxWarningBody=SEE FULL PRESCRIBING INFORMATION FOR...") | |||
.jpg){kind=link}
|
|
17:11 | Cryptogenic cirrhosis 6 changes history +3,131 [Imam Ali Shah (6×)] | |||
|
|
17:11 (cur | prev) +8 Imam Ali Shah talk contribs Tag: Visual edit | ||||
|
|
17:03 (cur | prev) +419 Imam Ali Shah talk contribs (Added CT scan images) Tag: Visual edit | ||||
|
|
16:45 (cur | prev) +1,626 Imam Ali Shah talk contribs (Added CT scan images) Tag: Visual edit | ||||
|
|
16:34 (cur | prev) +269 Imam Ali Shah talk contribs Tag: Visual edit | ||||
|
|
16:26 (cur | prev) +476 Imam Ali Shah talk contribs Tag: Visual edit | ||||
|
|
16:21 (cur | prev) +333 Imam Ali Shah talk contribs Tag: Visual edit | ||||
| 16:03 | User:Imam Ali Shah diffhist −61 Imam Ali Shah talk contribs | ||||
| N 14:44 | Template:VSRN diffhist +81 Rithish Nimmagadda talk contribs (Created page with "Rithish Nimmagadda,MBBS.[mailto:rithishnvs@gmail.com]") | ||||
|
|
N 14:30 | FRUZAQLA 3 changes history +9,129 [Rithish Nimmagadda (3×)] | |||
|
|
14:30 (cur | prev) +2 Rithish Nimmagadda talk contribs Tag: Visual edit | ||||
|
|
14:25 (cur | prev) +35 Rithish Nimmagadda talk contribs | ||||
| N |
|
14:10 (cur | prev) +9,092 Rithish Nimmagadda talk contribs (Created page with "{{DrugProjectFormSinglePage |aOrAn=a |indicationType=treatment |indication=FRUZAQLA is a kinase inhibitor indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine‑, oxaliplatin‑, and irinotecan‑based chemotherapy, an anti‑VEGF therapy, and, if RAS wild‑type and medically appropriate, an anti-EGFR therapy. |adverseReactions=Most common adverse reactions ( are hypertension, palma...") | |||
|
|
N 14:21 | User:Rithish Nimmagadda 3 changes history +362 [Rithish Nimmagadda (3×)] | |||
|
|
14:21 (cur | prev) −9 Rithish Nimmagadda talk contribs (→Your Name) | ||||
|
|
14:21 (cur | prev) +9 Rithish Nimmagadda talk contribs (→Your Name) | ||||
| N |
|
14:20 (cur | prev) +362 Rithish Nimmagadda talk contribs (Created page with "<nowiki> __NOTOC__ ==Your Name== ''' Rithish Nimmagadda, MBBS Research scholar <br />Contact:945-278-1660 <br /> Email: rithishnvs@gmail.com [mailto:rithishnvs@gmail.com]<br /> ==Current Position== * research scholar (list chapters here)<br /> ==Education== Medical Degree from Kamineni Academy of Medical sciences and research centre , Hyderabad , India") | |||
| N 13:32 | Fruzaqla diffhist +49 Rithish Nimmagadda talk contribs (Created page with "{{DrugProjectFormSinglePage |authorTag=rithish }}") | ||||
|
|
04:13 | Zuranolone 2 changes history +5,755 [Alen Antony (2×)] | |||
|
|
04:13 (cur | prev) +2,528 Alen Antony talk contribs | ||||
|
|
03:48 (cur | prev) +3,227 Alen Antony talk contribs | ||||
| 01:58 | User:Edzelco diffhist +22 Edzelco talk contribs (→Pages Authored/Co-authored/Collaborated) | ||||